Sounds like good progress is continuing to be made across all sectors and the product range building a good reputation, which can be seen in the increase in sales revenue and improvement in margin.
I expect to see strong growth continuing in the 2nd half year and a number of new announcements, and it looks like announcements that provide indications of their $ value.
Body armour and Eclipsys are gaining traction and the new Business Development Manager busy and in contact with most Body Armour suppliers - I expect new deals and expansion into other complimentary product lines going forward [likely in the next few months], assisted also by the 2nd new hire a supply chain expert who can aid in optimising customer / potential customer outcomes.
The new line of credit will also help support cash flows.
All in all I think Alexium has shown that it has turned a corner and it will be reporting continuing growth going forward.
AJX Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
